It’s time for a dive into the biggest pre-market stock movers for Friday as we check out the winners and losers this morning!
Moving stocks today are earnings reports, collaborations, clinical trial data, and more.
Let’s get into that below!
Pre-Market Stock Movers: 10 Top Gainers
- Yunji (NASDAQ:YJ) stock is rocketing more than 74% with the release of its .
- U Power (NASDAQ:UCAR) shares are soaring over 47% as it continues to rally .
- Better Choice (NYSEMKT:BTTR) stock is surging more than 36% after .
- LAVA Therapeutics (NASDAQ:LVTX) shares are rising over 31% after picking a .
- MongoDB (NASDAQ:MDB) stock is increasing close to 27% after .
- Vivos Therapeutics (NASDAQ:VVOS) shares are gaining more than 26% on Friday morning.
- Connect Biopharma (NASDAQ:CNTB) stock is heading over 21% higher alongside positive .
- Sigma Additive Solutions (NASDAQ:SASI) shares are jumping more than 18% on Friday.
- Powerbridge Technologies (NASDAQ:PBTS) stock is getting an over 17% boost today.
- Lululemon Athletica (NASDAQ:LULU) shares are up nearly 15% after .
10 Top Losers
- Kiora Pharmaceuticals (NASDAQ:KPRX) stock is plummeting almost 37% .
- SentinelOne (NYSE:S) shares are diving close to 37% with in its latest earnings report.
- Oncorus (NASDAQ:ONCR) stock is tumbling more than 29% .
- Trxade Health (NASDAQ:MEDS) shares are taking a nearly 18% beating on Friday morning.
- Tigo Energy (NASDAQ:TYGO) stock is dropping over 12% after rallying yesterday.
- Ascent Solar Technology (NASDAQ:ASTI) shares are falling more than 11% today.
- Wejo (NASDAQ:WEJO) stock is sliding over 10% today.
- Nephros (NASDAQ:NEPH) shares are slipping almost 10% after rallying on Thursday.
- China Liberal Education (NASDAQ:CLEU) stock is dipping more than 9% after a rally yesterday.
- Monopar Therapeutics (NASDAQ:MNPR) shares close out our pre-market stock movers down over 9% following a jump .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
